Phase I clinical trial testing the dose escalation and expansion of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin administration (PITHAC) for the management of pleural carcinosis.

Autor: Chriqui LE; Division of Thoracic Surgery, University Hospital of Lausanne, Rue du Bugnon 46 1011, Lausanne, Switzerland., Abdelnour-Berchtold E; Division of Thoracic Surgery, University Hospital of Lausanne, Rue du Bugnon 46 1011, Lausanne, Switzerland., Zanfrini E; Division of Thoracic Surgery, University Hospital of Lausanne, Rue du Bugnon 46 1011, Lausanne, Switzerland., Devesa-Perez S; Division of Thoracic Surgery, University Hospital of Lausanne, Rue du Bugnon 46 1011, Lausanne, Switzerland., Gonzalez M; Division of Thoracic Surgery, University Hospital of Lausanne, Rue du Bugnon 46 1011, Lausanne, Switzerland., Krueger T; Division of Thoracic Surgery, University Hospital of Lausanne, Rue du Bugnon 46 1011, Lausanne, Switzerland., Ellefsen K; Sponsor Research Office (SRO, University Hospital of Lausanne, Rue du Bugnon 46 1011, Lausanne, Switzerland., Destaillats A; Sponsor Research Office (SRO, University Hospital of Lausanne, Rue du Bugnon 46 1011, Lausanne, Switzerland., Bonnet D; Sponsor Research Office (SRO, University Hospital of Lausanne, Rue du Bugnon 46 1011, Lausanne, Switzerland., Hübner M; Division of Visceral Surgery, University Hospital of Lausanne, Rue du Bugnon 46 1011, Lausanne, Switzerland., Bouchaab H; Division of Oncology, University Hospital of Lausanne, Rue du Bugnon 46 1011, Lausanne, Switzerland., Bassani-Sternberg M; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Peters S; Division of Oncology, University Hospital of Lausanne, Rue du Bugnon 46 1011, Lausanne, Switzerland., Cavin S; Division of Thoracic Surgery, University Hospital of Lausanne, Rue du Bugnon 46 1011, Lausanne, Switzerland., Perentes JY; Division of Thoracic Surgery, University Hospital of Lausanne, Rue du Bugnon 46 1011, Lausanne, Switzerland. Electronic address: jean.perentes@chuv.ch.

Publikováno v: Cancer treatment and research communications [Cancer Treat Res Commun] 2024 Dec 17; Vol. 42, pp. 100858. Date of Electronic Publication: 2024 Dec 17.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Cyclosporin A as an Add-On Therapy to a Corticosteroid-Based Background Treatment in Patients with COVID-19: A Multicenter, Randomized Clinical Trial.

Autor: Llanos Jiménez, Lucía¹ (AUTHOR) balvarez@quironsalud.es, Alvarez-Alvarez, Beatriz¹ (AUTHOR) gpeces@quironsalud.es, Fonseca Aizpuru, Eva² (AUTHOR) evamfonseca@yahoo.es, Peces-Barba, Germán¹ (AUTHOR) mjrodriguezn@fjd.es, Pindao Quesada, Gloria³ (AUTHOR) gloria.pindao@hgvillalba.es, Rodríguez Nieto, Mª Jesús^1,3 (AUTHOR) osanchez@fjd.es, Ruiz-Hornillos, Francisco J.^4,5 (AUTHOR) javier.ruiz@quironsalud.es, Seijo Maceiras, Luis⁶ (AUTHOR) lseijo@unav.es, Robles Barrena, Ignacio⁷ (AUTHOR) iroblesb@hospitalreyjuancarlos.es, Mena-de-Cea, Alvaro⁸ (AUTHOR) alvaro.mena.de.cea@sergas.es, Meijide-Míguez, Héctor⁹ (AUTHOR) hector.meijide@quironsalud.es, Sánchez-Pernaute, Olga¹ (AUTHOR)

Publikováno v: Journal of Clinical Medicine. Sep2024, Vol. 13 Issue 17, p5242. 11p.

To what extent can clinical characteristics be used to distinguish encephalitis from encephalopathy of other causes? Results from a prospective observational study.

Autor: Quist-Paulsen E; Department of Infectious Diseases, Oslo University Hospital Ullevaal, P. O. Box 4956, Nydalen, N-0450, Oslo, Norway. elpa1@ous-hf.no.; Institute of Clinical Medicine, University of Oslo, P.O Box 1171, Blindern, 0318, Oslo, Norway. elpa1@ous-hf.no., Kran AB; Institute of Clinical Medicine, University of Oslo, P.O Box 1171, Blindern, 0318, Oslo, Norway.; Department of Microbiology, Oslo University Hospital, P.O. Box 4956, Nydalen, N0450, Oslo, Norway.; Faculty of Medicine, University of Oslo, P.O Box 1078, Blindern, 0316, Oslo, Norway., Lindland ES; Institute of Clinical Medicine, University of Oslo, P.O Box 1171, Blindern, 0318, Oslo, Norway.; Department of Radiology and Nuclear Medicine, Oslo University Hospital, Rikshospitalet, Sognsvannsveien 20, N-0372, Oslo, Norway.; Sorlandet Hospital Arendal, Sykehusveien 1, N-4809, Arendal, Norway., Ellefsen K; Department of Neurology, Oslo University Hospital, Ullevaal Hospital, P.O. Box 4956, N-0450, Oslo, Norway., Sandvik L; Oslo Group of Biostatistics and Epidemiology Oslo University Hospital, P.O. Box 4950, Sogn Arena, N-0424, Oslo, Norway., Dunlop O; Department of Acute Medicine, Oslo University Hospital, Ullevaal Hospital, P. O. Box 4956, Nydalen, N-0450, Oslo, Norway., Ormaasen V; Department of Infectious Diseases, Oslo University Hospital Ullevaal, P. O. Box 4956, Nydalen, N-0450, Oslo, Norway.

Publikováno v: BMC infectious diseases [BMC Infect Dis] 2019 Jan 22; Vol. 19 (1), pp. 80. Date of Electronic Publication: 2019 Jan 22.

Exploring the extrachromosomal plasmid rDNA of Naegleria fowleri AY27 genotype II: A human brain-eating amoeba via high-throughput sequencing.

Autor: Aurongzeb, Muhammad¹ (AUTHOR), Hafiz Malik, Muhammad Talha² (AUTHOR), Jahanzaib, Muhammad¹ (AUTHOR), Hassan, Syed Shah^1,3 (AUTHOR), Rashid, Yasmeen⁴ (AUTHOR) yasmeen.rashid@uok.edu.pk, Aziz, Tariq⁵ (AUTHOR), Alharbi, Metab⁶ (AUTHOR)

Publikováno v: BMC Medical Genomics. 5/7/2024, Vol. 17 Issue 1, p1-10. 10p.